Hussain M - Search Results

1

Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results.

Ben-Josef E, Porter AT, Han S, Mertens W, Chuba P, Fontana J, Hussain M. Ben-Josef E, et al. Among authors: hussain m. Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):699-703. doi: 10.1016/s0360-3016(00)01375-4. Int J Radiat Oncol Biol Phys. 2001. PMID: 11172951

2

Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.

Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, Tang DG, Wood DP. Honn KV, et al. Among authors: hussain m. Pathol Oncol Res. 1996 Mar;2(1-2):98-109. doi: 10.1007/BF02893960. Pathol Oncol Res. 1996. PMID: 18443924 Free article.

3

Adjuvant chemo-/hormonal therapy trials for locally advanced prostate cancer.

Vaishampayan U, Hussain M. Vaishampayan U, et al. Among authors: hussain m. Curr Oncol Rep. 2000 Sep;2(5):402-8. doi: 10.1007/s11912-000-0059-z. Curr Oncol Rep. 2000. PMID: 11122871 Review.

4

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.

Pienta KJ, Redman B, Hussain M, Cummings G, Esper PS, Appel C, Flaherty LE. Pienta KJ, et al. Among authors: hussain m. J Clin Oncol. 1994 Oct;12(10):2005-12. doi: 10.1200/JCO.1994.12.10.2005. J Clin Oncol. 1994. PMID: 7523606 Clinical Trial.

5

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.

Hussain M, Vaishampayan U, Du W, Redman B, Smith DC. Hussain M, et al. J Clin Oncol. 2001 May 1;19(9):2527-33. doi: 10.1200/JCO.2001.19.9.2527. J Clin Oncol. 2001. PMID: 11331332

6

Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.

Hussain M, Salwen W, Kucuk O, Ensley J. Hussain M, et al. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-43-S19-45. Semin Oncol. 1997. PMID: 9427265 Clinical Trial.

7

Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916.

Hussain M, Petrylak D, Fisher E, Tangen C, Crawford D. Hussain M, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):55-60. Semin Oncol. 1999. PMID: 10604271

8

Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma.

Trivedi C, Redman B, Flaherty LE, Kucuk O, Du W, Heilbrun LK, Hussain M. Trivedi C, et al. Among authors: hussain m. Cancer. 2000 Jul 15;89(2):431-6. doi: 10.1002/1097-0142(20000715)89:2<431::aid-cncr31>3.0.co;2-b. Cancer. 2000. PMID: 10918176 Clinical Trial.

9

Radiation therapy for a rising PSA level after radical prostatectomy.

Tiguert R, Forman JD, Hussain M, Wood DP Jr. Tiguert R, et al. Among authors: hussain m. Semin Urol Oncol. 1999 Aug;17(3):141-7. Semin Urol Oncol. 1999. PMID: 10462317 Review.

10

Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma.

Vaishampayan U, Flaherty L, Du W, Hussain M. Vaishampayan U, et al. Among authors: hussain m. Cancer. 2001 Aug 1;92(3):519-23. doi: 10.1002/1097-0142(20010801)92:3<519::aid-cncr1350>3.0.co;2-#. Cancer. 2001. PMID: 11505395 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,464 results

Search Page

Filters